121 related articles for article (PubMed ID: 1421033)
1. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases.
Cooper EH; Forbes MA; Hancock AK; Parker D; Laurence V
Biomed Pharmacother; 1992; 46(1):31-6. PubMed ID: 1421033
[TBL] [Abstract][Full Text] [Related]
2. Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma.
Díaz-Martín MA; Traba ML; De La Piedra C; Guerrero R; Méndez-Dávila C; De La Peña EG
Scand J Clin Lab Invest; 1999 Apr; 59(2):125-32. PubMed ID: 10353326
[TBL] [Abstract][Full Text] [Related]
3. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
Morris PG; Fazio M; Farooki A; Estilo C; Mallam D; Conlin A; Patil S; Fleisher M; Cremers S; Huryn J; Hudis CA; Fornier MN
J Oral Maxillofac Surg; 2012 Dec; 70(12):2768-75. PubMed ID: 22330331
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
Murphy GP; Troychak MJ; Cobb OE; Bowes VA; Kenny RJ; Barren RJ; Kenny GM; Ragde H; Holmes EH; Wolfert RL
Prostate; 1997 Oct; 33(2):141-6. PubMed ID: 9316655
[TBL] [Abstract][Full Text] [Related]
7. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
Body JJ; Dumon JC; Blocklet D; Darte C
Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of alkaline phosphatase and bone-specific alkaline phosphatase for metastases in breast cancer: a systematic review and meta-analysis.
Jiang C; Hu F; Li J; Gao G; Guo X
Breast Cancer Res Treat; 2023 Nov; 202(2):233-244. PubMed ID: 37522998
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis.
Jiang C; Hu F; Xia X; Guo X
Int J Biol Markers; 2023 Mar; 38(1):25-36. PubMed ID: 36775971
[TBL] [Abstract][Full Text] [Related]
10. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer.
Reale MG; Santini D; Marchei GG; Manna A; Del Nero A; Bianco V; Marchei P; Frati L
Int J Biol Markers; 1995; 10(1):42-6. PubMed ID: 7629426
[TBL] [Abstract][Full Text] [Related]
11. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA
J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026
[TBL] [Abstract][Full Text] [Related]
12. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
Ureña P; Prieur P; Pétrover M
Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
Pectasides D; Farmakis D; Nikolaou M; Kanakis I; Kostopoulou V; Papaconstantinou I; Karamanos NK; Economopoulos T; Raptis SA
J Pharm Biomed Anal; 2005 Feb; 37(1):171-6. PubMed ID: 15664758
[TBL] [Abstract][Full Text] [Related]
14. Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma.
Stieber P; Nagel D; Ritzke C; Rössler N; Kirsch CM; Eiermann W; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):809-14. PubMed ID: 1489855
[TBL] [Abstract][Full Text] [Related]
15. Bone alkaline phosphatase in children with chronic renal failure.
Behnke B; Kemper M; Kruse HP; Müller-Wiefel DE
Nephrol Dial Transplant; 1998 Mar; 13(3):662-7. PubMed ID: 9550644
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
[TBL] [Abstract][Full Text] [Related]
17. Serum ostase in the follow-up of breast cancer patients.
Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
[TBL] [Abstract][Full Text] [Related]
18. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK
J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061
[TBL] [Abstract][Full Text] [Related]
19. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
[TBL] [Abstract][Full Text] [Related]
20. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
